Latuda lurasidone regulatory update

FDA approved an sNDA from Dainippon's Sunovion Pharmaceuticals Inc. subsidiary to expand the recommended dose range of Latuda lurasidone to include once-daily 120 and 160 mg/day and to include a 120 m...